TrialJournal of the American College of Cardiology2013

Cardiovascular event reduction versus new-onset diabetes during atorvastatin therapy: effect of baseline risk factors for diabetes.

David D Waters et al.PubMed ↗Publisher ↗

No numbers read from the abstract.